The role of prostasomes in PCa is discussed, focusing on their possibility to offer a non-invasive test, complementing the poor specificity of the blood prostate antigen (PSA) biomarker for PCa diagnosis. This evidence concerns the gene KLK3 and posterior cortical atrophy.